newsfilter
← Latest News
PR Newswire·

Nuvation Bio to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 2, 2026

  • Nuvation Bio Inc. (NYSE: NUVB) will host a conference call & webcast on Monday, March 2, 2026, at 4:30 p.m. ET.
  • The event will discuss financial results & business updates for the fourth quarter & full year of 2025.
  • Investors & the public can register via the Investor Relations section of the Nuvation Bio website.
  • Participants can access the live call by dialing +1 833-470-1428 (U.S. toll-free) & entering access code 833155.
  • An archived recording will be available on the company website for 90 days following the event.
  • Nuvation Bio's pipeline includes taletrectinib (IBTROZI®), safusidenib, NUV-868, & a drug-drug conjugate program.
  • The company was founded in 2018 by David Hung, M.D., & maintains offices in New York, San Francisco, Boston, & Shanghai.